Lightnews — Scholar-powered news

Simon Pfisterer

@spfisterer.bsky.social

98 followers 160 following 23 posts

Science and technology shape the world. Hope I can help along the path with my research group www.pfistererlab.org and as a founder of www.moncytehealth.com a novel precision medicine company.

Posts Media Videos Starter Packs

Pinned

Simon Pfisterer @spfisterer.bsky.social · Jun 25

Extremely happy that our work got accepted in #ATVB! We functionally profiled 400 biobank samples, linking cellular lipid uptake, storage and handling to treatment outcomes of statin therapy and residual cardiovascular risk.

www.ahajournals.org/doi/10.1161/...

1 6

Reposted by Simon Pfisterer

European Atherosclerosis Society @eassociety.bsky.social · 14d

The EU High-Level Event on cardiovascular health is happening right now at the European Parliament 🇪🇺. Patients, policymakers & experts are coming together to highlight why early screening for FH and Lp(a) must become a European priority.

1 4

Simon Pfisterer @spfisterer.bsky.social · 21d

Cycling to work refreshes my brain and improves cardiovascular health! It is also super beautiful if you work in #Helsinki

@eassociety.bsky.social #cholesterol #cvd

2 1 7

Simon Pfisterer @spfisterer.bsky.social · 28d

Dear @barteltlab.bsky.social and the organizing team! Thank you for putting all of this together and keeping the show running. It is a lot of work -- big thank you and applause!

Simon Pfisterer @spfisterer.bsky.social · 28d

The European Lipoprotein Club Meeting #ELC is special! Great to be back, meeting friends and discussing our latest data from www.moncytehealth.com! @eassociety.bsky.social @barteltlab.bsky.social

1 1 5

Reposted by Simon Pfisterer

Guillaume Jacquemet @guijacquemet.bsky.social · 29d

Come and work with us 5-year position available for a University Researcher in Bioimaging 1.11.2025-31.12.2030

abo.rekrytointi.com/paikat/index...

University Researcher in Bioimaging / Universitetsforskare med inriktning bioimaging, 1.11.2025-31.12.2030

abo.rekrytointi.com

38 35

Reposted by Simon Pfisterer

European Atherosclerosis Society @eassociety.bsky.social · 29d

Join us for a special session in recognition of Familial Hypercholesterolaemia (FH) Awareness Week. This webinar features the recorded session from EAS 2025 in Glasgow, highlighting key insights into FH diagnosis, treatment, and global strategies.

Register here: eas.to/WebSep24Reg

1 2

Reposted by Simon Pfisterer

Gaëlle Letort @gaellel.bsky.social · Sep 4

We (with @nicolasdray.bsky.social @zenlabpasteur.bsky.social) are happy to release officially FishFeats, our #napari plugin to streamline 3D smFish/RNA quantification! 🎊
Available here: github.com/gletort/Fish... user documentation: gletort.github.io/FishFeats/

1 21 45

Simon Pfisterer @spfisterer.bsky.social · Sep 2

It was great to be there! A big thank you to all of those who made it possible!

European Society of Cardiology @escardio.bsky.social · Sep 2

More than 3,000 ESC Volunteers make possible everything the ESC does – from congresses guidelines and journals to data science, education, public health advocacy and more.

Thank you for giving the global CV healthcare community, and patients, the gift of time.

#ESCCongress #ESC75Years #ESCTV

Simon Pfisterer @spfisterer.bsky.social · Sep 2

It was great to present our latest data at #ESC Congress in #Madrid and to catch up with colleagues and friends at one of the most important cardiology conferences! Huge event with great science and clinical data + Madrid is a nice city! @eassociety.bsky.social #moncyte-health #cholesterol #CVD

1 3

Simon Pfisterer @spfisterer.bsky.social · Aug 25

It was very nice recording this podcast and talking about our research at @helsinki.fi and forming the startup company www.moncytehealth.com!

2 4

Reposted by Simon Pfisterer

Reese Richardson @reeserichardson.bsky.social · Aug 4

Today, our article "The entities enabling scientific fraud at scale are large, resilient, and growing rapidly" is finally published in PNAS. I hope that it proves to be a wake-up-call for the whole scientific community.

reeserichardson.blog/2025/08/04/a...

A do-or-die moment for the scientific enterprise

Reflecting on our paper “The entities enabling scientific fraud at scale are large, resilient, and growing rapidly”

reeserichardson.blog

9 190 320

Reposted by Simon Pfisterer

Rocket Lab @rocketlabcorp.com · Aug 12

It’s official, we’ve acquired Geost! Adding space-based missile defense, space protection & space domain awareness sensors to our extensive portfolio of capabilities, securing the technology needed for next-generation defense initiatives & U.S. national security missions - bit.ly/3UmNjRF

7 11 49

Simon Pfisterer @spfisterer.bsky.social · Aug 7

Science and innovation are bringing humankind forward. With positive impact on jobs, tax revenue, health and wellbeing. @helsinki.fi and other universities in Finland and around the globe are great examples. Support in them is crucial. Like a seed turning into a great flower!

University of Helsinki @helsinki.fi · Aug 7

"Esitys yliopistojen rahoituksen leikkaamisesta on täysin käsittämätön ajassa, jossa talouskasvu sakkaa jo valmiiksi”, sanoo rehtorimme Sari Lindblom valtionvarainministeriön ehdotuksesta. www.helsinki.fi/fi/uutiset/k...

Rehtori Sari Lindblom: “Satojen miljoonien yliopistoleikkauksilla Suomi uppoaisi vain syvemmälle suohon” | Helsingin yliopisto

Valtiovarainministeriön ehdotus valtion vuoden 2026 budjetiksi julkaistiin 6. elokuuta. Esitys sisältää mittavia, satojen miljoonien leikkauksia yliopistojen, tutkimuksen ja innovaatioiden rahoituksee...

www.helsinki.fi

Reposted by Simon Pfisterer

Alexander Bartelt @barteltlab.bsky.social · Aug 4

I’m happy that research and development in Germany 🇩🇪 are striving - still so many things to do adopt an open and inclusive culture at German universities.

EMBO @embo.org · Aug 4

Supporting the #LifeSciences community through different programmes and schemes, scientific #publishing, #policy as well as #innovation, EMBO champions scientific excellence throughout #Europe and worldwide.

This week’s feature: #Germany

www.embo.org/the-embo-com...
🧪 #research #opportunities

EMBO communities in EMBC Member States – Focus on Germany

Germany’s research and innovation ecosystem is the largest in Europe, and the country regularly ranks as one of the leaders in innovation globally

www.embo.org

4 10

Reposted by Simon Pfisterer

European Atherosclerosis Society @eassociety.bsky.social · Aug 4

As rates of obesity and related metabolic disorders continue to rise globally, the need for an integrated approach to care has never been greater. Join our webinar & learn how this three-stage model offers a holistic strategy for risk reduction, with clear criteria at each step: eas.to/WebOct21Reg

1 3

Reposted by Simon Pfisterer

@LaBonneLaB @labonnelab.bsky.social · Jul 26

Some journals are claiming that you need to pay big $$ for gold open access to comply with NIH's new public access policy. FYI that is total bs. You can comply by depositing the Accepted Manuscript into PubMed Central on the Date of Publication without embargo. Pass it on.

6 64 120

Reposted by Simon Pfisterer

henrietteautzen.bsky.social @henrietteautzen.bsky.social · Aug 3

🚨 One week left to apply!
I am hiring a fully funded PhD fellow and a postdoc to work on membrane protein structural biology and pharmacology at Univ Copenhagen

Come work with a great team and exciting projects in a collaborative environment!

🔗 Links to the ads in comments

#CryoEM #AcademicJobs

2 12 19

Reposted by Simon Pfisterer

Technische Universität München @tum.de · Aug 4

BioLabs|TUM, a new #biotechnology hub launched by TUM Venture Labs, BioLabs, and Eli Lilly and Company, will open in 2026 in central #Munich. The site will offer lab space, mentoring and networks to early-stage #startups: go.tum.de/297087

#Entrepreneurship

📷BioLabs

BioLabs|TUM launched to foster start-ups

The TUM Venture Labs, BioLabs and Eli Lilly and Company (Lilly) today launched BioLabs|TUM, a new biotechnology innovation hub.

go.tum.de

3 3

Reposted by Simon Pfisterer

NewAmsterdam Pharma Corporation @newamsterdampharma.bsky.social · Aug 4

p-Tau217 is emerging as an important biomarker that can be used to help diagnose and monitor Alzheimer’s disease progression. Levels increase years before memory symptoms appear, making it a helpful indicator for early detection.

Get to know this powerful biomarker: bit.ly/47cfrOK

p-Tau217 is an important blood-based biomarker of Alzheimer’s disease

1 1

Reposted by Simon Pfisterer

Rocket Lab @rocketlabcorp.com · Jul 30

We’re ready to make the next era of human spaceflight to Mars possible.

Rocket Lab’s Mars Telecommunications Orbiter is designed to deliver real-time, high-bandwidth communications on the Red Planet.

🔗 Learn more: bit.ly/415yjeL

9 40

Reposted by Simon Pfisterer

Thierry Galli 🧫🧬🔬🎸🔊 @tgalli.bsky.social · Jul 24

ER_2025 #endoplasmicreticulum #ER #conference Paris October 8-10 2025 Register! itbcrde.inserm.fr/index.php?page…

8 9

Simon Pfisterer @spfisterer.bsky.social · Jul 24

It was great to record an #AtheroTalk podcast and talk about our research and establishing the spinout company www.moncytehealth.com! A big thank you to the #AtheroTalk Team, especially Sanne M. and @azinkh.bsky.social for interviewing me and doing the recording. It has been a very nice experience!

Azin Kheirkhah @azinkh.bsky.social · Jul 23

🎧 Have you listened to the latest episode of #AtheroTalk yet? It’s out now and definitely worth a listen!
@spfisterer.bsky.social
@eassociety.bsky.social

🔗 Tune in now👇🏼
Spotify:
open.spotify.com/episode/5X2j...
#CardioSky
#MedSky
#academia

1 3

Reposted by Simon Pfisterer

European Atherosclerosis Society @eassociety.bsky.social · Jul 23

We've launched new expert-led Short Track Courses, designed to equip healthcare professionals with focused, up-to-date knowledge in key areas of lipidology and cardiovascular prevention: eas.to/ShortTracks. All courses are free for EAS members, including National Society and complimentary members.

1 4 4

Reposted by Simon Pfisterer

European Atherosclerosis Society @eassociety.bsky.social · Jul 16

This autumn, we’re launching a new series of Advanced Courses on Non-classical risk factors for cardiovascular disease. Choose the location closest to you and register now:
Sweden: eas.to/NCRFSWEReg
Austria: eas.to/NCRFATReg
Italy: eas.to/NCRFITReg
United Kingdom: eas.to/NCRFUKReg

1 1